Inflammatory markers of lung disease in adult patients with cystic fibrosis. - Wikidata - awgldk - TriplyDB

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

http://www.wikidata.org/entity/Q35749974

about

Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy.Isolation and characterization of microparticles in sputum from cystic fibrosis patients The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosis.Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis.Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort.Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study.Sputum biomarkers of inflammation in cystic fibrosis lung disease Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients Highlights of a workshop to discuss targeting inflammation in cystic fibrosis C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations.Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.Vitamin D bioavailability in cystic fibrosis: a cause for concern?Novel end points for clinical trials in young children with cystic fibrosis Vitamin D treatment modulates immune activation in cystic fibrosis.Elevated IgG4 serum levels in patients with cystic fibrosis.Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis.Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Vitamin E intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis.Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study.

P2860

Q33989498-502C15D8-7A9E-434F-A775-821551A5FD4F Q34020055-DDCBA201-E692-4186-99B7-22EF7702A99A Q34158550-9649FFD4-DCAE-49FA-9344-B7872223D979 Q34309058-FF2FBC34-F8EB-4A20-A26C-E9D8FFCE3181 Q34479408-A1A44493-C400-4C46-BD72-B7C19AD281DB Q34493723-571FF4AC-680D-4CA4-9EAC-BA47D3600ABB Q36723908-4843EA03-7F51-41EC-92C7-AFC4A1FA6D56 Q36847677-188E37D7-AC9B-48D8-A99B-7F8413E60820 Q36891552-91424866-6991-43A8-8ED7-38DEF8A85719 Q36956804-15EC741A-0D24-4024-8A56-C07DCC864F88 Q37330935-315F6F0B-AD8E-43B6-8E61-0F466ABCE4C5 Q37568497-60050179-31B3-4462-86C5-E88C54439B64 Q37700674-21C103D1-FD27-41B5-9AC6-ECC4699B2586 Q38005772-0B03C991-F216-4F11-BC7C-D1CACB2BBEE9 Q38111791-C050CF8D-FD5F-40B8-8046-025C8D4C254A Q38805531-85BB69B6-44A9-428C-B976-9F7D996B3B2F Q41702615-F3021FF4-DEB0-4FFB-A748-E0309CF13918 Q43244889-775DB48A-C6E8-431F-B8B4-8836C0EA448C Q47831284-352C94AE-CAF6-441C-B5F1-5B4CF230DB4D Q51650842-C82941A5-CC7D-429C-87F3-BC14A19B4DB7 Q54387118-BB81795F-8126-4104-A35C-1B3D9271A030

P2860

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

http://www.wikidata.org/entity/Q35749974

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

@ast

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

@en

type

label

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

@ast

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

@en

prefLabel

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

@ast

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

@en

P1433

Q35749974-B8A84A2C-97EE-462A-A437-53ACA363E15D

P1476

Q35749974-4B5C7F64-DD22-483B-B5F9-0B9786FC8879

P2093

Q35749974-1E334514-9B91-45D7-A725-DF697EF611F4

Q35749974-5BE83195-81FB-46A9-A8D5-144E045712E2

Q35749974-6DEDFCEE-27E9-4EFE-B176-3EDBEEC88A82

Q35749974-782C61A0-D882-4E2F-B986-AF46EA0F3404

Q35749974-96E0C244-7B69-4DEE-BE65-1E0D186E3FDA

Q35749974-A1CA0872-A0CB-4FD6-AC31-1635A732E872

Q35749974-CF6EBD7B-4B90-4CE0-9650-72D080801132

Q35749974-DD417142-D127-46E2-A3F2-CC5DCEAD94A3

Q35749974-E5DC68BE-66DB-4CFA-81A5-2F5405920E5E

P2860

Q35749974-07F1046E-4E13-44C1-ABB5-CD1F9C5A6BEA

Q35749974-0881017E-7965-43F4-A8E8-2D80CF9AC8F1

Q35749974-0C0F1121-D24D-4A1F-8441-84C91E3DD607

Q35749974-1A421A06-40BB-4846-B9A0-21CF0DB97FCE

Q35749974-1D92D210-2C90-408B-9FE9-369768969540

Q35749974-2C43A447-3DB5-45B0-8037-C6C40F0586E8

Q35749974-30DD6E1E-7833-4CFD-B890-8A06196AA3CD

Q35749974-37FFD6A4-ED1D-4704-84C5-FD18908CE34D

Q35749974-408CD5AA-CED1-40AD-B941-A945CFC3D60E

Q35749974-450C9521-0F23-4626-AB3C-7DC79FC2C831

P304

Q35749974-E5A8735A-1B6C-4254-8AED-1A142027A858

P31

Q35749974-84A23C7C-4E44-4862-84C9-B9E559611A1D

P356

Q35749974-714FE18A-2650-4CB6-BD45-D300402846C2

P433

Q35749974-88A70429-B47A-49C3-95F7-37FDDFEF3939

P478

Q35749974-C6736A31-561F-419F-8FED-3D1CEB903AE1

P577

Q35749974-730F3DA4-CD1D-4280-AF76-9F5A8E6B54AB

P698

Q35749974-6F93A835-69AC-444E-B606-B2D1287882E2

P921

Q35749974-CE217843-1BD6-43E4-B5A8-7315A5CA0FAF

P932

Q35749974-D87092F1-5B85-4099-B687-E604AC729626

P356

P1433

Pediatric Pulmonology

P1476

Inflammatory markers of lung disease in adult patients with cystic fibrosis.

@en

P2093

Craig Gerard

http://www.w3.org/2001/XMLSchema#string

Edwin K Silverman

http://www.w3.org/2001/XMLSchema#string

Gerald B Pier

http://www.w3.org/2001/XMLSchema#string

Hara Levy

http://www.w3.org/2001/XMLSchema#string

Ian Huntington

http://www.w3.org/2001/XMLSchema#string

Juan C Celedón

http://www.w3.org/2001/XMLSchema#string

Leslie A Kalish

http://www.w3.org/2001/XMLSchema#string

Nathaniel Weller

http://www.w3.org/2001/XMLSchema#string

Scott T Weiss

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

Standardization of Spirometry, 1994 Update. American Thoracic Society

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.

Need to test the arterial inflammation hypothesis.

Changes in the normal maximal expiratory flow-volume curve with growth and aging.

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.

Mechanisms and markers of airway inflammation in cystic fibrosis.

Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery.

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

Noninvasive biomarkers of airway inflammation in cystic fibrosis.

P304

256-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PPUL.20563

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17245735

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

4469989

http://www.w3.org/2001/XMLSchema#string